You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 26, 2024

Sciegen Pharms Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for SCIEGEN PHARMS INC, and what generic and branded alternatives to SCIEGEN PHARMS INC drugs are available?

SCIEGEN PHARMS INC has sixty-three approved drugs.



Summary for Sciegen Pharms Inc
US Patents:0
Tradenames:47
Ingredients:46
NDAs:63

Drugs and US Patents for Sciegen Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms Inc ARIPIPRAZOLE aripiprazole TABLET, ORALLY DISINTEGRATING;ORAL 207240-002 Apr 18, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc NAPROXEN naproxen TABLET;ORAL 212517-003 Feb 21, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 211282-001 Jan 10, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 204597-003 Mar 16, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 205519-001 May 19, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 214092-003 May 7, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc QUETIAPINE FUMARATE quetiapine fumarate TABLET, EXTENDED RELEASE;ORAL 209635-002 Nov 29, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.